Sawmills
Seed Round in 2025
Sawmills is a technology company that specializes in AI-driven telemetry data management. Its platform, designed for enterprises, processes and monitors data from engineering teams, enhancing reliability and quality. By identifying cost reduction opportunities and improving critical monitoring capabilities, Sawmills helps businesses manage their telemetry data efficiently and securely.
Dune Security
Seed Round in 2025
AI fighting AI. CISOs face an impossible risk landscape today. 80% of cybersecurity breaches start because of employee error. The problem is exacerbating with generative AI, as a single hacker can specifically target thousands of employees in the same amount of time that they used to specifically target tens of employees with social engineering. CISOs lack tools to deal with employee risk and are held accountable when a breach inevitably happens. By leveraging AI at each step, Dune Security empowers organizations to quantify individual risk through analyzing user behavior, context, learning patterns, and third party data. This allows the automation of tailored cybersecurity measures to each individual, transforming vulnerabilities into strengths. Dune is the central engine of all employee risk data, which is a solution that is not just timely for organizations but necessary in navigating the present cybersecurity landscape. This gives the CISO the capability to understand who are the high risk employees, to what extent, and why - as well as automatically remediate and restrict access to keep their organization safe. Today, Dune Security uniquely replaces legacy and ineffective security awareness training by pinpointing the crucial 8% of employees responsible for 80% of the risk, ensuring all employees receive personalized, machine learning-driven training tailored to their risk profile. CISOs also have easy access to quantifiable data via robust reporting and API-out capability, enabling them to both report to compliance auditors, regulators, and insurance underwriters, as well as restrict access to high-risk employees through other security systems.
Precision Neuroscience
Series C in 2024
Precision Neuroscience, founded in 2021 and based in New York, develops next-generation brain-computer interface technology aimed at treating neurological illnesses. The company's platform is designed to be minimally invasive and safely removable, with the capability to process large amounts of data. This technology enables direct connection between the human brain and artificial intelligence, offering potential breakthrough treatments for the one billion patients worldwide affected by neurological conditions.
MetaSight Diagnostics
Series A in 2024
MetaSight Diagnostics, a health technology company, is on a mission to develop affordable and precise liquid biopsy diagnostics for the early detection of a wide range of chronic and acute diseases by leveraging proprietary mass spectrometry technologies (metabolomics, lipidomics, and proteomics).
CytoVale, Inc. is a medical technology company based in San Francisco, California, that specializes in developing innovative biomarkers utilizing the mechanical properties of individual cells, a field known as mechanomics. Founded in 2013, the company employs microfluidics technology to effectively route and physically probe single cells, allowing for the simultaneous measurement of multiple biomarkers. This approach aims to enhance early detection and diagnosis of immune-mediated diseases, particularly sepsis. By leveraging cell mechanics and machine learning, CytoVale seeks to revolutionize the diagnostic landscape, ultimately improving patient outcomes and reducing treatment costs in healthcare.
Centaur Labs
Series B in 2024
Centaur Labs is a provider of medical data annotation services that focuses on enhancing medical decision-making and diagnosis. The company operates a platform that leverages the collective intelligence of a global network of tens of thousands of students and professionals, who compete to deliver high-quality data annotation. By offering precise medical data labeling and analysis, Centaur Labs contributes to the development of advanced medical AI applications. This approach not only aids healthcare providers in making informed decisions but also aims to improve patient outcomes while reducing costs associated with healthcare.
Distributional
Series A in 2024
Distributional is a company focused on enhancing the safety, reliability, and security of artificial intelligence systems. It develops an AI testing and evaluation platform that offers tools for continuous monitoring, generating test cases, and analyzing results. This platform ensures that AI systems perform as intended, allowing organizations to trust their AI implementations. By providing these capabilities, Distributional enables customers to deploy AI products more frequently and harness the full potential of AI within their operations.
Infactory
Seed Round in 2024
Infactory is a developer of an artificial intelligence search tool aimed at providing reliable and accurate search results. The company's platform integrates high-quality data partnerships with both conventional and cutting-edge technologies. This combination enables users to access clear, precise, and trustworthy information efficiently, eliminating unnecessary complexities.
Bionic Health
Seed Round in 2024
Bionic Health is a company that offers preventative health services, focusing on individuals experiencing chronic pain. It has developed a digital healthcare platform that emphasizes frequent diagnostics and utilizes machine learning to create tailored treatment plans. This approach allows patients to gain personalized insights based on their unique health data, enabling them to make impactful changes over time. The platform is designed to provide continuous, closely monitored preventative care throughout the year, with an emphasis on slowing the aging process and improving overall health outcomes.
BeyondTrucks
Series A in 2024
BeyondTrucks is a technology company focused on transforming the operations of large private and specialty trucking fleets through its innovative platform. The platform provides configurable solutions for process automation and optimization, enabling fleets to move away from outdated software and manual methods. By harnessing automation, smart data, and integrated financial services, BeyondTrucks offers a comprehensive trucking workflow management system that connects various operational components. This approach facilitates efficient logistics management and promotes a driver-centric transportation model. As the industry reaches a technological inflection point, BeyondTrucks stands out as a leader in modernizing fleet operations and enhancing decision-making capabilities.
Multiscale Technologies
Series A in 2024
Multiscale Technologies is a company focused on enhancing research and development in materials science through its advanced AI platform. This platform accelerates the discovery of new materials by a factor of 100, enabling manufacturing companies involved in R&D to optimize their processes effectively. By digitizing diverse forms of data, such as tabular data, PDFs, and simulations, the platform integrates this information through a unique knowledge fusion system. This allows for seamless connections between experiments, simulations, and domain expertise in materials science. As a result, Multiscale Technologies provides predictive analyses and actionable recommendations, fostering innovation and data-driven advancements in various research domains.
Clarium Health
Venture Round in 2024
Clarium Health is a developer of an artificial intelligence-based platform aimed at enhancing healthcare operations. The company's innovative platform automates various business processes within healthcare settings by collecting and analyzing data from existing systems. It filters out noise, errors, and outliers to accurately predict demand, allowing hospitals and healthcare centers to optimize staffing and inventory management. This capability helps prevent shortages and stockouts, reduces supplier lead times, and identifies alternative products when necessary. By empowering healthcare providers with intelligent workflow automation and actionable insights, Clarium Health is transforming the efficiency and effectiveness of healthcare delivery.
Consensus
Series A in 2024
The consensus is to enable discovery and consumption of the world's expert knowledge. No matter your background, finding scientific research has always been a difficult procedure. Consensus think AI has the potential to transform this equation if applied intelligently, deftly, and tastefully.
Sawmills
Seed Round in 2024
Sawmills is a technology company that specializes in AI-driven telemetry data management. Its platform, designed for enterprises, processes and monitors data from engineering teams, enhancing reliability and quality. By identifying cost reduction opportunities and improving critical monitoring capabilities, Sawmills helps businesses manage their telemetry data efficiently and securely.
Hopscotch Primary Care
Series C in 2024
Operator of a data-driven healthcare startup intended to transform healthcare in rural communities through exceptional care, bringing better access and quality service to its patients. The company delivers tailored quality care through a team-based model, with resources and support for patients, inside and outside clinics, thereby enabling healthcare professionals to provide the support and care that patients need.
caVos biotherapeutics
Seed Round in 2024
An emerging genomic and data science company, developing novel drugs based on naturally occurring resistance mechanisms
Multitude Insights
Seed Round in 2024
Multitude Insights is a technology company based in Watertown, Massachusetts, founded in 2021. It specializes in assisting law enforcement agencies by helping them manage and analyze their unstructured data. The company's platform is designed to quickly process large amounts of information about suspects, issue bulletins, track trends in real-time, enhance search accuracy, and facilitate collaboration between different departments. This enables public safety stakeholders to effectively utilize their data to maintain community safety.
NobleAI is a developer of a science-based artificial intelligence platform aimed at revolutionizing the development of chemical and material products. By utilizing its advanced AI technology, the company enables organizations to accelerate product development, reduce costs, and enhance the performance and sustainability of their offerings. NobleAI's platform transforms traditional materials development strategies by providing actionable insights and reliable predictions, facilitating faster innovation and enabling companies to bring superior and more environmentally friendly products to market efficiently.
Truleo is a company that specializes in body camera audio analytics, addressing the challenge of reviewing police body camera footage, of which less than 1% is typically analyzed. The platform automatically processes and categorizes 100% of body camera videos for law enforcement agencies across the nation. It detects critical events such as use-of-force incidents, pursuits, and non-compliance, while also screening for both professional and unprofessional officer language. By leveraging proprietary models developed by law enforcement experts, Truleo generates actionable reports that provide insights into officer behavior and interactions. This capability facilitates improved supervision, coaching, and training, ultimately enhancing police professionalism and fostering trust within the community. The company's mission focuses on using body camera analytics to promote positive interactions between law enforcement and the public.
Ocient Inc., founded in 2018 and based in Chicago, Illinois, specializes in providing analytical software solutions tailored for database management. The company has developed a data analytics platform capable of rapidly analyzing vast datasets, which can range from tens of terabytes to exabytes and contain trillions or quadrillions of rows. This platform excels in ingesting billions of rows per second, performing filtering operations, and computing aggregate results at remarkable speeds, reaching up to trillions of rows per second. By leveraging this technology, organizations can effectively harness and analyze large datasets with both scale and velocity, facilitating informed decision-making and insights.
Mineral Forecast
Seed Round in 2024
Mineral Forecast is a technology company that specializes in enhancing mineral exploration through the application of artificial intelligence. It has developed a drilling support system that digitally transforms the exploration process by analyzing drilling data. This system enables mining companies to quantitatively assess and prioritize potential drilling sites, thereby optimizing their exploration efforts. By leveraging advanced AI algorithms, Mineral Forecast helps to accelerate resource discovery, reduce operational costs associated with drilling campaigns, and improve the overall success rate of exploration projects. The company's innovative approach aims to make mineral exploration more efficient and effective for mining operations.
Alvee is a developer of an artificial intelligence-driven tool designed to enhance health equity and improve overall health outcomes. The company offers a solution that provides real-time, patient-specific alerts when health equity issues are identified for individual patients. By integrating social determinants of health, chronic conditions, demographic information, and risks associated with health inequity, Alvee's tool grants healthcare providers and payers a comprehensive view of a patient's health equity status. This approach not only assists in advancing health equity initiatives but also helps organizations fulfill data stratification quality reporting requirements effectively.
Lightbeam.ai
Series A in 2024
LightBeam.ai is a leading innovator in data security and privacy automation, dedicated to helping organizations manage and access sensitive data securely. The company's platform utilizes advanced data management techniques, including entity linkage and deep learning, to efficiently scan and comprehend documents, speech, and natural language processing at scale. This technology operates seamlessly across various third-party virtual clouds or managed services, allowing clients to integrate data from diverse sources and generate actionable insights while safeguarding data privacy and confidentiality. LightBeam.ai empowers privacy and compliance executives to maintain continuous compliance, while also providing information security executives with assurance that sensitive data is accessed and utilized securely. Through its identity-centric discovery and classification engine, LightBeam integrates data cataloging, access, and sharing into a cohesive privacy control system.
Consensus
Seed Round in 2023
The consensus is to enable discovery and consumption of the world's expert knowledge. No matter your background, finding scientific research has always been a difficult procedure. Consensus think AI has the potential to transform this equation if applied intelligently, deftly, and tastefully.
Hayden AI
Series B in 2023
Hayden AI is a technology company focused on developing artificial intelligence and machine learning solutions aimed at enhancing urban mobility and public transit systems. The company specializes in automated enforcement of dedicated bus lanes and bus stops, which contributes to faster public transportation, increased street safety, and sustainability. By leveraging an autonomous traffic management platform, Hayden AI utilizes advanced technologies and a network of connected mobile devices to improve urban life and support the creation of smarter cities. Its AI-powered mobility solutions are designed to detect, analyze, and address traffic incidents, ultimately enhancing the quality of life for communities.
Clarium Health
Seed Round in 2023
Clarium Health is a developer of an artificial intelligence-based platform aimed at enhancing healthcare operations. The company's innovative platform automates various business processes within healthcare settings by collecting and analyzing data from existing systems. It filters out noise, errors, and outliers to accurately predict demand, allowing hospitals and healthcare centers to optimize staffing and inventory management. This capability helps prevent shortages and stockouts, reduces supplier lead times, and identifies alternative products when necessary. By empowering healthcare providers with intelligent workflow automation and actionable insights, Clarium Health is transforming the efficiency and effectiveness of healthcare delivery.
CytoVale, Inc. is a medical technology company based in San Francisco, California, that specializes in developing innovative biomarkers utilizing the mechanical properties of individual cells, a field known as mechanomics. Founded in 2013, the company employs microfluidics technology to effectively route and physically probe single cells, allowing for the simultaneous measurement of multiple biomarkers. This approach aims to enhance early detection and diagnosis of immune-mediated diseases, particularly sepsis. By leveraging cell mechanics and machine learning, CytoVale seeks to revolutionize the diagnostic landscape, ultimately improving patient outcomes and reducing treatment costs in healthcare.
OpsLab specializes in creating predictive operations tracking and disruption management platforms tailored for industries such as airlines, hospitals, and defense organizations. The company's AI-based platform addresses complex optimization problems by leveraging operations research techniques and machine learning. This technology provides enterprise SaaS products that assist with operational planning, tracking, and recovery, helping clients manage their resources more efficiently. For example, in the airline industry, OpsLab's solutions automate squadron schedule planning and sortie reflowing, while for defense organizations, it aids in managing aircrews and ground staff operations.
OfferFit is an AI-powered experimentation platform that automates decision-making and personalization for businesses, enhancing customer engagement strategies. It utilizes a self-learning artificial intelligence-based decision engine to segment customers and identify optimal offers tailored to each group. By leveraging machine learning, OfferFit continuously tests various promotions and interactions, enabling companies to refine their marketing approaches based on customer responses. This technology not only improves the effectiveness of marketing campaigns but also elevates the overall customer experience through personalized recommendations.
Graft is a modern artificial intelligence platform that empowers data teams to develop production-ready AI solutions with minimal effort and without requiring specialized machine learning skills. The company offers a cloud-native platform designed for the analysis of unstructured data, including text, images, video, audio, and graphs. By leveraging advanced AI technologies, Graft enables clients to effectively analyze and utilize unstructured data, facilitating improved decision-making and business outcomes. This data-centric approach allows organizations to harness the power of foundation models, thereby streamlining the process of building and deploying AI applications without the need for extensive infrastructure or dedicated teams.
Ellipsis Health
Series A in 2023
Ellipsis Health, Inc. is a technology company based in San Francisco, California, founded in 2013. It specializes in developing innovative analytics solutions that integrate patient speech and clinical data to assess mental health and well-being. By utilizing artificial intelligence, Ellipsis Health aims to enhance behavioral health outcomes through the analysis of natural conversation. The company has created a platform that generates clinical-grade assessments of anxiety and depression severity, as well as sub-clinical evaluations of stress levels. This technology enables healthcare providers to continuously screen their patient populations, offering a cost-effective method to identify conditions such as depression and ensure patients receive timely support.
Kolors is a technology company that specializes in enhancing intercity bus transportation through an AI-enabled smart bus platform. The platform leverages artificial intelligence and data analytics to deliver a range of services, including route optimization, virtual stops, scheduling, and dynamic pricing. Additionally, it incorporates digital payment solutions and GPS tracking, alongside CCTV for security enhancements, which together facilitate a more efficient and safer travel experience. By providing these innovative tools, Kolors aims to support small and medium bus operators in improving their operational efficiency and revenue generation, while also enhancing the overall experience for passengers.
Jirav Inc. is a developer of cloud-based financial forecasting and analysis software tailored for small businesses. Founded in 2015 and headquartered in San Francisco, the company offers a platform that integrates financial and operational data, allowing users to explore historical performance and generate accurate forecasts for bookings, revenues, workforce, expenses, and cash flows. Jirav's software enables users to quickly assess plan versus actuals, utilize rolling forecasts, and visualize data to identify opportunities across various teams and departments. Additionally, it provides best practice templates that facilitate the creation of precise budgets and forecasts. The platform serves finance teams, accounting firms, and business leaders, streamlining financial planning and reporting processes while reducing reliance on error-prone spreadsheets.
AlliConnect
Seed Round in 2023
Alli Connect is a breakthrough B2B software for patient provider matching in mental health care. Our powerful technology proactively promotes wellness, improves patient clinical outcomes and eliminates the trial and error currently utilized in seeking treatment. Alli Connect’s platform is customized to each individual customer organization to drive high engagement and quantify effectiveness in access to care. The data gathered by the Alli Connect technology provides the ability to make data driven decision in mental health for Value Based Care. Our unique approach and technology has been validated by more than 5 years of data, increasing success in access to mental health care from 19% to 88%! Alli Connect was founded and is led by Colleen Hilton, a 2x founder and licensed mental health provider; with the unique industry knowledge required to successfully tackle the healthcare business market.
Dune Security
Pre Seed Round in 2023
AI fighting AI. CISOs face an impossible risk landscape today. 80% of cybersecurity breaches start because of employee error. The problem is exacerbating with generative AI, as a single hacker can specifically target thousands of employees in the same amount of time that they used to specifically target tens of employees with social engineering. CISOs lack tools to deal with employee risk and are held accountable when a breach inevitably happens. By leveraging AI at each step, Dune Security empowers organizations to quantify individual risk through analyzing user behavior, context, learning patterns, and third party data. This allows the automation of tailored cybersecurity measures to each individual, transforming vulnerabilities into strengths. Dune is the central engine of all employee risk data, which is a solution that is not just timely for organizations but necessary in navigating the present cybersecurity landscape. This gives the CISO the capability to understand who are the high risk employees, to what extent, and why - as well as automatically remediate and restrict access to keep their organization safe. Today, Dune Security uniquely replaces legacy and ineffective security awareness training by pinpointing the crucial 8% of employees responsible for 80% of the risk, ensuring all employees receive personalized, machine learning-driven training tailored to their risk profile. CISOs also have easy access to quantifiable data via robust reporting and API-out capability, enabling them to both report to compliance auditors, regulators, and insurance underwriters, as well as restrict access to high-risk employees through other security systems.
Limitless
Series A in 2023
Rewind is a personalized AI powered by everything you’ve seen, said, or heard.
Consensus
Seed Round in 2023
The consensus is to enable discovery and consumption of the world's expert knowledge. No matter your background, finding scientific research has always been a difficult procedure. Consensus think AI has the potential to transform this equation if applied intelligently, deftly, and tastefully.
NobleAI is a developer of a science-based artificial intelligence platform aimed at revolutionizing the development of chemical and material products. By utilizing its advanced AI technology, the company enables organizations to accelerate product development, reduce costs, and enhance the performance and sustainability of their offerings. NobleAI's platform transforms traditional materials development strategies by providing actionable insights and reliable predictions, facilitating faster innovation and enabling companies to bring superior and more environmentally friendly products to market efficiently.
Bionic Health
Seed Round in 2023
Bionic Health is a company that offers preventative health services, focusing on individuals experiencing chronic pain. It has developed a digital healthcare platform that emphasizes frequent diagnostics and utilizes machine learning to create tailored treatment plans. This approach allows patients to gain personalized insights based on their unique health data, enabling them to make impactful changes over time. The platform is designed to provide continuous, closely monitored preventative care throughout the year, with an emphasis on slowing the aging process and improving overall health outcomes.
Precision Neuroscience
Series B in 2023
Precision Neuroscience, founded in 2021 and based in New York, develops next-generation brain-computer interface technology aimed at treating neurological illnesses. The company's platform is designed to be minimally invasive and safely removable, with the capability to process large amounts of data. This technology enables direct connection between the human brain and artificial intelligence, offering potential breakthrough treatments for the one billion patients worldwide affected by neurological conditions.
Beekin is a developer of a real estate analytics platform that provides prescriptive analytics for multifamily operations. The company serves some of the world's largest family offices and private funds, optimizing over $5 billion in real estate daily and generating significant financial returns through data-driven insights. Beekin's platform offers real-time information on valuations, contract management, accounting, and reporting, allowing multifamily and single-family investors to make informed investment decisions. With a team comprising urban economists, AI experts, and former commercial real estate investors, Beekin combines data science with a profound understanding of the real estate market. The company emphasizes collaboration and transparency among investors, positioning itself as a leader in the evolving landscape of real estate analytics.
Solvo.ai
Seed Round in 2022
Solvo.ai is a developer of an artificial intelligence-based platform aimed at enhancing the resilience and efficiency of global supply chains. The company focuses on creating a human-influenced automated decision-making system that integrates human expertise with advanced machine learning technology. This platform is designed to facilitate better management of supply chain dynamics by offering an optimization engine that allows businesses to run scenarios, evaluate tradeoffs, and improve transparency. By addressing real-world challenges, Solvo.ai helps organizations respond effectively to disruptions and changing market conditions, enabling them to mitigate risks and achieve improved operational outcomes.
Multiscale Technologies
Venture Round in 2022
Multiscale Technologies is a company focused on enhancing research and development in materials science through its advanced AI platform. This platform accelerates the discovery of new materials by a factor of 100, enabling manufacturing companies involved in R&D to optimize their processes effectively. By digitizing diverse forms of data, such as tabular data, PDFs, and simulations, the platform integrates this information through a unique knowledge fusion system. This allows for seamless connections between experiments, simulations, and domain expertise in materials science. As a result, Multiscale Technologies provides predictive analyses and actionable recommendations, fostering innovation and data-driven advancements in various research domains.
Kalderos
Venture Round in 2022
Kalderos, Inc. is a healthcare technology company that specializes in drug discount management solutions. Founded in 2016 and headquartered in Chicago, Illinois, with an additional location in Brookfield, Wisconsin, Kalderos offers a software-as-a-service (SaaS) platform designed to analyze and optimize the coordination of drug discount programs for healthcare providers, manufacturers, and payers. The platform employs advanced models and machine learning processes to identify and resolve non-compliance issues, detect inconsistencies, and provide data management capabilities. By offering features such as claims verification, dispute resolution, and discount monitoring, Kalderos enables its clients to streamline the communication and payment processes associated with drug discounts, ultimately eliminating waste and enhancing efficiency in the healthcare system.
Knowde is a software platform designed for the chemical industry, facilitating digital transformation for global chemical producers and distributors. It operates an online marketplace that enhances the accessibility of trading chemicals, polymers, and industrial ingredients. Leveraging the world's largest, purpose-built chemical taxonomy, Knowde employs advanced technologies, including deep learning, to enable users to efficiently search, filter, sample, quote, and purchase products tailored to their needs. This innovative approach allows clients to compare offerings from various suppliers, streamlining procurement processes and unlocking new opportunities within chemical operations.
Moving Analytics
Series A in 2022
Moving Analytics is a telehealth service provider that specializes in cardiovascular prevention programs. Its first product Movn is an end-to-end, integrated program to deliver remote and virtual cardiac rehab. The platform reduces readmissions and empowers the effective and efficient delivery of quality care to patients based on 30+ years of research in remote disease management from Stanford University.
Veritonic
Series A in 2022
Veritonic, Inc. is a marketing analytics company specializing in audio, founded in 2015 and based in New York. The company provides a comprehensive platform that leverages artificial intelligence to analyze and measure audio assets such as music, voiceovers, jingles, and audio logos. By offering insights into qualitative and quantitative marketing responses, Veritonic enables brands, agencies, and publishers to effectively evaluate the impact of their audio campaigns at various stages—pre-market, in-market, and post-campaign. This research-driven approach helps clients optimize their audio investments, mitigate risks, and enhance consumer engagement through compelling audio experiences, ultimately increasing the return on their audio marketing efforts.
Quadrant Health
Pre Seed Round in 2022
Quadrant Health is a healthcare technology company founded in 2021 by Krishna Gorrepati and Anin Sayana. The company specializes in a cloud-based platform that provides real-time analysis of electronic health records and patient messaging data. By employing advanced machine learning algorithms, Quadrant Health's platform aims to identify potential health risks, such as infections and injuries, before symptoms manifest. This proactive approach enables healthcare providers to manage patient care more effectively and enhances efforts in preventative medicine, ultimately striving to improve patient outcomes and reduce the likelihood of harm.
BeyondTrucks
Seed Round in 2022
BeyondTrucks is a technology company focused on transforming the operations of large private and specialty trucking fleets through its innovative platform. The platform provides configurable solutions for process automation and optimization, enabling fleets to move away from outdated software and manual methods. By harnessing automation, smart data, and integrated financial services, BeyondTrucks offers a comprehensive trucking workflow management system that connects various operational components. This approach facilitates efficient logistics management and promotes a driver-centric transportation model. As the industry reaches a technological inflection point, BeyondTrucks stands out as a leader in modernizing fleet operations and enhancing decision-making capabilities.
GridMatrix
Seed Round in 2022
GridMatrix develops digital infrastructure software aimed at alleviating traffic congestion, reducing emissions, and minimizing accidents in urban environments. The company's innovative solution leverages existing city infrastructure, including intersection cameras and sensors, to gather real-time data. By processing this information alongside cloud-based mobility data, GridMatrix provides cities with actionable insights and analytics. This enables municipalities to autonomously manage traffic flows, optimize traffic signal timing, and predict potential congestion and accident hotspots, ultimately enhancing intersection efficiency and safety.
Odaia is a developer of an AI-powered Customer Data Platform tailored for the Life Sciences industry. The company has pioneered the integration of process mining, customer journey mapping, and artificial intelligence to provide goal-driven commercial insights and process automation. Through its predictive analytics and commercial insights platform, Odaia assists clients in facilitating personalized selling. This innovative solution enables pharmaceutical commercial teams to analyze data effectively, ensuring that therapeutics reach the patients who need them. Odaia's focus on leveraging advanced technology positions it as a leader in enhancing the efficiency and effectiveness of sales strategies within the healthcare sector.
Curbside Health
Seed Round in 2022
Curbside Health develops clinical decision support software that aligns health systems and clinicians to more efficiently deliver optimal care. The company was founded by physicians and technologists to combine the best of clinical evidence with the realities of healthcare delivery and with opportunities of modern web technology. We support health systems and hospitals to expand their clinical content library (e.g. clinical pathways, protocols, guidelines, A3s, checklists, etc) and enhance the utilization of these resources at the point-of-care. Together, the components of Curbside's platform enable a hospital to improve clinical outcomes and operational efficiencies. Product development is informed by working closely with patients, clinicians, engineers, physicians, healthcare administrators, and payors. Our mission is hiding in plain sight within our name, and those in healthcare will understand: every medical decision is informed in real-time by the world's expert of that particular situation, while simultaneously accounting for hospital policy and all relevant patient-specific data. Essentially, Curbside is on a never-ending quest to perfect medical decision making.
AlliConnect
Seed Round in 2022
Alli Connect is a breakthrough B2B software for patient provider matching in mental health care. Our powerful technology proactively promotes wellness, improves patient clinical outcomes and eliminates the trial and error currently utilized in seeking treatment. Alli Connect’s platform is customized to each individual customer organization to drive high engagement and quantify effectiveness in access to care. The data gathered by the Alli Connect technology provides the ability to make data driven decision in mental health for Value Based Care. Our unique approach and technology has been validated by more than 5 years of data, increasing success in access to mental health care from 19% to 88%! Alli Connect was founded and is led by Colleen Hilton, a 2x founder and licensed mental health provider; with the unique industry knowledge required to successfully tackle the healthcare business market.
AlliConnect
Seed Round in 2022
Alli Connect is a breakthrough B2B software for patient provider matching in mental health care. Our powerful technology proactively promotes wellness, improves patient clinical outcomes and eliminates the trial and error currently utilized in seeking treatment. Alli Connect’s platform is customized to each individual customer organization to drive high engagement and quantify effectiveness in access to care. The data gathered by the Alli Connect technology provides the ability to make data driven decision in mental health for Value Based Care. Our unique approach and technology has been validated by more than 5 years of data, increasing success in access to mental health care from 19% to 88%! Alli Connect was founded and is led by Colleen Hilton, a 2x founder and licensed mental health provider; with the unique industry knowledge required to successfully tackle the healthcare business market.
OfferFit is an AI-powered experimentation platform that automates decision-making and personalization for businesses, enhancing customer engagement strategies. It utilizes a self-learning artificial intelligence-based decision engine to segment customers and identify optimal offers tailored to each group. By leveraging machine learning, OfferFit continuously tests various promotions and interactions, enabling companies to refine their marketing approaches based on customer responses. This technology not only improves the effectiveness of marketing campaigns but also elevates the overall customer experience through personalized recommendations.
TripleBlind
Series A in 2021
TripleBlind operates an online platform that enables entities to collaborate on sensitive data and algorithms without compromising privacy. Founded in 2019 and headquartered in Kansas City, Missouri, the company provides a software-only solution delivered via a simple API. This solution focuses on healthcare and financial services, leveraging principles like federated learning and multi-party compute to enhance scalability and processing speed. TripleBlind supports major cloud platforms and ensures compliance with regulations such as HIPAA and GDPR, making it a robust tool for unlocking the intellectual property value of data while preserving privacy. The company is backed by notable investors including Accenture, General Catalyst, and The Mayo Clinic.
Civis Analytics
Series B in 2021
Civis Analytics, Inc. is a data science software company that empowers organizations to make data-driven decisions. Founded in 2013 and based in Chicago, Illinois, Civis offers a range of tools and services, including the Civis platform for predictive analytics, which facilitates end-to-end data workflows. The company's offerings include the Community Outreach and Engagement Hub, designed for government and nonprofit teams to effectively reach and engage their target audiences; the Census Intelligence Center, which aids census coordinators and leadership; and various tools for audience targeting and message testing. Additionally, Civis provides data science consulting, consumer insights, market research, and media optimization services. By combining advanced software solutions with expertise in data science and survey methodology, Civis Analytics helps both public and private sector organizations enhance their decision-making processes and achieve a competitive edge.
Olaris is a biotechnology company focused on transforming disease diagnosis and treatment through its innovative CEREBRO platform, which integrates metabolomics and machine learning. Founded in 2013 and headquartered in Framingham, Massachusetts, Olaris aims to enhance precision medicine by utilizing the body’s natural communication systems to identify biomarkers essential for treatment responsiveness. Through its myOLARIS™ precision diagnostics pipeline, the company collaborates with healthcare providers to tailor therapeutic approaches, thereby optimizing patient outcomes and minimizing adverse effects. Olaris is dedicated to advancing personalized healthcare solutions that improve the efficacy of medical interventions.
Nixtla
Pre Seed Round in 2021
Nixtla is a company that specializes in providing advanced forecasting tools and software development platforms for businesses across various industries. Its mission is to democratize access to data-driven decision-making by enabling organizations of all sizes to harness the power of sophisticated algorithms and predictive analytics. Nixtla's platform allows developers and data scientists to build open-source forecasting software, facilitating the creation of time series processing services in the cloud. By utilizing continuous integration and deployment, clients can efficiently deploy APIs and develop features tailored to their temporal data needs. The company's focus on cutting-edge forecasting and anomaly detection empowers users to reduce uncertainty and enhance their decision-making capabilities, regardless of their team's size or technical expertise.
Hayden AI
Series A in 2021
Hayden AI is a technology company focused on developing artificial intelligence and machine learning solutions aimed at enhancing urban mobility and public transit systems. The company specializes in automated enforcement of dedicated bus lanes and bus stops, which contributes to faster public transportation, increased street safety, and sustainability. By leveraging an autonomous traffic management platform, Hayden AI utilizes advanced technologies and a network of connected mobile devices to improve urban life and support the creation of smarter cities. Its AI-powered mobility solutions are designed to detect, analyze, and address traffic incidents, ultimately enhancing the quality of life for communities.
Shakudo
Seed Round in 2021
Shakudo is a developer of an end-to-end machine learning platform that simplifies the management of data stacks and enhances compatibility among leading data tools. By focusing on accelerating artificial intelligence projects, Shakudo empowers AI teams to transition from ideation to production in a fraction of the usual time. The platform enables data science and machine learning teams to scale and customize their computational resources efficiently with minimal coding. This approach allows teams to produce tangible results in the form of market-ready products, reducing their dependency on engineering resources to bring their research to fruition.
AdaptX is a Seattle-based healthcare technology company established in 2016, spun out from Seattle Children's Hospital. It specializes in data analytics, visualization, and AI for hospitals and surgery centers. The company's core product is a clinical healthcare analytics platform that integrates with institutions' existing electronic data systems. This platform enables medical professionals to monitor, analyze, and improve clinical outcomes and workflows, ultimately enhancing care quality and reducing costs. AdaptX empowers both medical leaders and frontline clinicians to make data-driven decisions, transforming clinical operations within healthcare providers' facilities.
Pave helps consumer and SMB credit risk teams increase approvals through AI-powered cashflow analytics. 100 million+ US consumers and businesses are financially underserved, simply because their data is not recognized by the traditional financial system. We solve this by transforming transaction data, loan performance outcomes, and credit reports into Cashflow-driven Attributes and Scores, enabling increased financial access to new customer segments without increasing risk. Our mission is to build a future where every person and business has access to equitable credit solutions by creating a new standard of Cashflow-driven Analytics.
Zone7
Convertible Note in 2021
Zone7 is a company that specializes in artificial intelligence-based software designed to predict sports injuries and optimize athletic performance. Founded in 2017 and headquartered in Palo Alto, California, Zone7 collects and analyzes data from various sources, including wearable devices, medical records, and fitness profiles. The software aims to identify injury risks before they occur, enabling coaching staff and medical professionals to make informed decisions regarding training, rest, and work assignments. Zone7's technology is utilized by over 30 professional sports franchises and is also applied in hospitals to monitor the well-being of medical staff. By providing actionable insights, Zone7 enhances the health, potential, and durability of athletes and the elite workforce, ultimately aiming to improve human performance across various fields.
AllHere Education
Series A in 2021
AllHere, Inc. is a Boston-based company that focuses on reducing chronic absenteeism in K-12 schools through its intervention management platform. The platform offers various tools, including referral management to analyze chronic absence data at multiple levels, intervention tracking applications for monitoring attendance interventions such as home visits and mentoring, and automated analytics reports to assess the effectiveness of intervention programs. Additionally, AllHere employs artificial intelligence and supervised machine learning to enhance its chatbot software, facilitating real-time, one-on-one communication between schools and families. This approach aims to create engaging experiences that support student recruitment, retention, and success by providing timely assistance and information to families.
Intrinio is a financial data company that provides an accessible and affordable platform for financial data through its application programming interface. The company's mission is to empower investors by reducing the time spent on data collection, entry, and analysis, which is often hampered by traditional financial data providers' high costs and restrictive technology. Intrinio's marketplace offers a wide range of financial data feeds, including fundamentals, economic data, insider transactions, institutional holdings, and earnings estimates, all delivered in user-friendly formats. This approach enables developers to create innovative financial analytics products while allowing investors to concentrate on critical tasks such as testing assumptions and conducting research. By fostering collaboration among data providers, developers, and investors, Intrinio aims to transform the financial data industry and enhance the overall investment experience.
Datanomix
Series A in 2021
Datanomix, Inc. is a software company based in Nashua, New Hampshire, established in 2015. It specializes in providing a machine data analytics platform that delivers real-time insights into manufacturing productivity for industrial manufacturers. The company's software integrates machine data streams, extending its functionality beyond conventional data visualization and process productivity tools. This allows manufacturers of all sizes to access advanced decision-making resources, thereby enhancing their production efficiency, performance, and profitability. By focusing on production intelligence, Datanomix aims to support the next generation of manufacturing environments.
Intus Care
Seed Round in 2021
Intus Care, Inc. is a healthcare analytics company that specializes in connecting home care providers with patients through its innovative platform. Founded in 2018 and based in North Providence, Rhode Island, the company leverages machine learning and electronic health records to enhance the efficiency of care delivery. Its application enables provider organizations to conduct electronic visit verification and predict hospital readmissions and utilization risks. Additionally, Intus Care's platform facilitates automatic patient risk grouping and tracking, identifies patients at high risk for hospitalization, and sends alerts regarding changes in patient health status to care coordination teams. By synthesizing financial, clinical, and administrative data, Intus Care helps healthcare organizations, including PACE programs and long-term care facilities, visualize trends and implement data-driven interventions aimed at improving patient care and reducing hospitalizations for vulnerable populations.
PulseData AI
Series A in 2021
PulseData AI, established in 2015 and headquartered in New York, specializes in healthcare technology. It develops machine learning software that helps healthcare providers identify patients at high risk of adverse, preventable medical outcomes. The company's platform analyzes vast amounts of patient data to predict health trends, enabling care management teams to deliver timely, targeted care, and ultimately reduce preventable illnesses and medical costs.
Scipher Medicine
Series C in 2021
Scipher Medicine Corporation is a biotechnology company based in Waltham, Massachusetts, that specializes in precision medicine for patients with autoimmune and cardiovascular diseases. The company has developed a molecular technology platform that utilizes blood samples to analyze RNA and predict patient responses to drug therapies. Its primary offerings include PrismDx tests, which identify patients who may not respond to certain medications, ensuring they can be prescribed alternative treatments. Notably, the PrismRA test assesses patients with rheumatoid arthritis to determine their likelihood of responding to anti-TNF therapies, while PrismUC serves a similar purpose for patients with ulcerative colitis. By focusing on the underlying disease biology rather than just symptoms, Scipher Medicine aims to optimize treatment from the outset, potentially reducing the healthcare costs associated with ineffective therapies. Established in 2013 and rebranded in 2015, Scipher Medicine is committed to transforming drug prescription practices and advancing drug development through its innovative approach.
Hayden AI
Seed Round in 2021
Hayden AI is a technology company focused on developing artificial intelligence and machine learning solutions aimed at enhancing urban mobility and public transit systems. The company specializes in automated enforcement of dedicated bus lanes and bus stops, which contributes to faster public transportation, increased street safety, and sustainability. By leveraging an autonomous traffic management platform, Hayden AI utilizes advanced technologies and a network of connected mobile devices to improve urban life and support the creation of smarter cities. Its AI-powered mobility solutions are designed to detect, analyze, and address traffic incidents, ultimately enhancing the quality of life for communities.
Lang.ai
Seed Round in 2021
Lang.ai is a language understanding platform that specializes in automating the processing and analysis of unstructured text data from various sources, including social networks and customer support interactions. Founded in 2012 and headquartered in Madrid, Spain, with additional offices in the United States and Mexico, the company utilizes artificial intelligence to streamline workflows associated with language processing. Lang.ai's platform enables users to automatically tag and categorize customer conversations using their own data, facilitating the identification of new patterns and insights. Key features include intent customization, real-time self-supervised classification, and advanced algorithmic preprocessing techniques such as tokenization and lemmatization. By optimizing these processes, Lang.ai aims to enhance operational efficiency and reduce costs for businesses across various sectors.
RapidSOS, Inc. is an emergency response data platform that connects life-saving information from over 350 million devices directly to 9-1-1 and first responders during emergencies. Founded in 2012 and based in New York, the company offers a range of solutions including Clearinghouse, which enables users to send emergency requests from RapidSOS-enabled devices, and an Emergency API suite that delivers user data to emergency services. Additionally, the RapidSOS Portal provides public safety agencies with secure access to essential Next Generation 911 (NG911) data. The platform supports more than 4,800 Emergency Communications Centers and plays a vital role in protecting over 90% of the U.S. population, responding to approximately 250 million emergencies annually. By collaborating with certified partners, RapidSOS enhances response capabilities by transmitting critical data such as precise location and real-time health information, ultimately aiming to improve emergency response efficiency and save lives.
Ocient Inc., founded in 2018 and based in Chicago, Illinois, specializes in providing analytical software solutions tailored for database management. The company has developed a data analytics platform capable of rapidly analyzing vast datasets, which can range from tens of terabytes to exabytes and contain trillions or quadrillions of rows. This platform excels in ingesting billions of rows per second, performing filtering operations, and computing aggregate results at remarkable speeds, reaching up to trillions of rows per second. By leveraging this technology, organizations can effectively harness and analyze large datasets with both scale and velocity, facilitating informed decision-making and insights.
Mage is a developer of an open-source coding tool that empowers businesses to leverage artificial intelligence for predictive analytics. The platform enables users to create and deploy machine-learning models efficiently, allowing for applications in areas such as churn prevention, product recommendations, and customer lifetime value assessment. By facilitating the import and transformation of data from various sources, Mage's technology simplifies the process of building, training, and integrating data into applications. The company's mission is to make AI technology accessible, enabling businesses to enhance customer experiences through innovative solutions.
FULLFILL
Seed Round in 2021
FULLFILL is a digital health platform that focuses on providing evidence-based corporate health programs aimed at improving employee well-being and reducing medical expenses for companies. Founded in 2019 and headquartered in Los Angeles, FULLFILL partners with employers to deliver virtual health coaching that addresses chronic conditions such as obesity, diabetes, and mental health issues. The program is conducted entirely online and features a wealth of resources, including videos, podcasts, articles, and interactive tools, supported by trained Master Coaches available 24/7. FULLFILL has demonstrated significant success, achieving high employee engagement and enrollment rates, and has reported improved health outcomes compared to traditional programs. With a strong emphasis on long-term results and a money-back guarantee, FULLFILL aims to address the increased health challenges faced by employees, particularly in the wake of COVID-19, while also serving as a valuable retention tool for employers.
Conversa Health
Series B in 2021
Conversa Health, Inc. is a company that specializes in patient relationship management solutions aimed at enhancing communication between patients and healthcare providers. Founded in 2013 and headquartered in Portland, Oregon, with additional offices in New York, Research Triangle Park, and San Francisco, Conversa offers a Virtual Care and Communication Platform designed to improve efficiency, patient engagement, and clinical outcomes. Its Digital Checkup platform automates personalized messaging based on comprehensive patient profiles developed from electronic health records, biometric devices, and self-reported data. The company serves a diverse clientele, including health systems, pharmaceutical companies, payers, and health tech firms, facilitating proactive communication and management of patients in various contexts, such as chronic care, oncology, and wellness. Conversa’s automated care platform effectively engages patients, triaging them to appropriate care settings when necessary, and has been adopted by notable organizations for its COVID-19 Virtual Care Programs, which include symptom checking, patient check-ins, and lab result delivery.
Ellipsis Health
Seed Round in 2021
Ellipsis Health, Inc. is a technology company based in San Francisco, California, founded in 2013. It specializes in developing innovative analytics solutions that integrate patient speech and clinical data to assess mental health and well-being. By utilizing artificial intelligence, Ellipsis Health aims to enhance behavioral health outcomes through the analysis of natural conversation. The company has created a platform that generates clinical-grade assessments of anxiety and depression severity, as well as sub-clinical evaluations of stress levels. This technology enables healthcare providers to continuously screen their patient populations, offering a cost-effective method to identify conditions such as depression and ensure patients receive timely support.
OmniPanel
Seed Round in 2020
OmniPanel is an analytics platform designed to extract valuable insights from customer support tickets. By analyzing user interactions, the platform helps businesses identify points of friction that affect customer retention and profitability. OmniPanel's approach emphasizes collaboration within a unified workspace, allowing organizations to prioritize the customer's voice in their decision-making processes. This capability enables businesses to enhance their customer experience and make data-driven product decisions, ultimately leading to more effective customer service and improved engagement.
FreightFlows
Venture Round in 2020
FreightFlows, Inc. is a maritime market intelligence company headquartered in Boston, Massachusetts, founded in 2018. It specializes in providing predictive analytics for global trade, catering to traders, shippers, owners, and brokers. The company's platform enables users to source, synthesize, and analyze real-time market data, which helps optimize operational decision-making and manage risks. FreightFlows offers insights into market, port, and fleet activity trends, including vessel availability, routes, and estimated arrival times. Additionally, it enhances visibility into commodity cargoes and trade activities while providing market analysis services that assist clients in trading futures, reducing commercial risk, and hedging against freight rate volatility.
Civis Analytics
Series A in 2020
Civis Analytics, Inc. is a data science software company that empowers organizations to make data-driven decisions. Founded in 2013 and based in Chicago, Illinois, Civis offers a range of tools and services, including the Civis platform for predictive analytics, which facilitates end-to-end data workflows. The company's offerings include the Community Outreach and Engagement Hub, designed for government and nonprofit teams to effectively reach and engage their target audiences; the Census Intelligence Center, which aids census coordinators and leadership; and various tools for audience targeting and message testing. Additionally, Civis provides data science consulting, consumer insights, market research, and media optimization services. By combining advanced software solutions with expertise in data science and survey methodology, Civis Analytics helps both public and private sector organizations enhance their decision-making processes and achieve a competitive edge.
Chooch specializes in generative AI technology that integrates computer vision and language understanding to create intelligent camera systems. Their AI Vision platform analyzes video streams in real-time, detecting visuals and actions, comprehending their significance, and triggering pre-programmed responses swiftly. This technology is designed to process a wide range of visual data, from infrared radiation sensors and x-rays to various applications, tagging objects of interest. Chooch's solutions aim to enhance efficiencies and ensure quality results for clients across different industries.
Unlearn.AI
Series A in 2020
Unlearn.AI, Inc. is a biotechnology company based in San Francisco, California, that specializes in developing innovative software tools for clinical research. Established in 2017, Unlearn.AI focuses on enhancing clinical trials through its unique digital twin technology, known as TwinRCT. This approach utilizes machine learning to create prognostic digital twins for individual patients, allowing for more accurate estimations of treatment effects while reducing the number of participants needed. The company also offers services for Clinical Trial Design, which helps determine inclusion criteria, endpoints, and study sizes, as well as Synthetic Control Arms that can minimize or eliminate the need for concurrent control groups. Additionally, Unlearn.AI provides Subgroup Analysis to identify and analyze specific patient subgroups within trial results. By integrating expertise from pharmaceuticals, medical technology, and machine learning, Unlearn.AI aims to transform clinical trials to improve outcomes for both patients and sponsors.
Usermind, Inc. is a technology company that specializes in creating a unified orchestration platform aimed at enhancing business operations and customer experiences. Founded in 2013 and headquartered in Seattle, Washington, Usermind addresses the challenges posed by siloed enterprise systems and fragmented customer data. Its platform integrates various SaaS applications and on-premise systems, facilitating entity mapping and the automation of complex customer journeys. By providing a customer data platform alongside a customer journey orchestration engine and analytics capabilities, Usermind enables organizations to deliver data-driven, omnichannel engagement throughout the customer lifecycle. This comprehensive approach empowers businesses to increase revenue, enhance customer engagement, and optimize costs.
Solsten is an AI company focused on understanding human behavior in the digital realm to enhance customer experiences. Founded in 2018 by Joe Schaeppi and Bastian Bergmann, the company is headquartered in Berlin, Germany. Solsten's platform is tailored for decision-makers in the gaming industry, including executives, researchers, and marketing professionals working within medium-to-large studios. The platform aids in user engagement by helping to find, retain, and monetize players, while also supporting user retention and developing new games. Solsten's technology allows gaming studios to identify their target audiences, reduce development costs, and expedite the market launch of their products.
Perennial
Venture Round in 2020
Cloud Agronomics Inc. is a geospatial imaging and analytics company that specializes in providing real-time analytics and predictive insights regarding crop performance to enhance agricultural practices. Founded in 2017 and headquartered in Lewes, Delaware, the company utilizes remote sensing technology to deliver actionable farm management insights. Its offerings include carbon monitoring, digital agronomy, and yield predictions, enabling farmers to identify and address crop disease outbreaks effectively. By providing these advanced analytical tools, Cloud Agronomics aims to optimize agricultural productivity and sustainability.
Kolors is a technology company that specializes in enhancing intercity bus transportation through an AI-enabled smart bus platform. The platform leverages artificial intelligence and data analytics to deliver a range of services, including route optimization, virtual stops, scheduling, and dynamic pricing. Additionally, it incorporates digital payment solutions and GPS tracking, alongside CCTV for security enhancements, which together facilitate a more efficient and safer travel experience. By providing these innovative tools, Kolors aims to support small and medium bus operators in improving their operational efficiency and revenue generation, while also enhancing the overall experience for passengers.
Conversa Health
Venture Round in 2020
Conversa Health, Inc. is a company that specializes in patient relationship management solutions aimed at enhancing communication between patients and healthcare providers. Founded in 2013 and headquartered in Portland, Oregon, with additional offices in New York, Research Triangle Park, and San Francisco, Conversa offers a Virtual Care and Communication Platform designed to improve efficiency, patient engagement, and clinical outcomes. Its Digital Checkup platform automates personalized messaging based on comprehensive patient profiles developed from electronic health records, biometric devices, and self-reported data. The company serves a diverse clientele, including health systems, pharmaceutical companies, payers, and health tech firms, facilitating proactive communication and management of patients in various contexts, such as chronic care, oncology, and wellness. Conversa’s automated care platform effectively engages patients, triaging them to appropriate care settings when necessary, and has been adopted by notable organizations for its COVID-19 Virtual Care Programs, which include symptom checking, patient check-ins, and lab result delivery.
Conversa Health
Series B in 2020
Conversa Health, Inc. is a company that specializes in patient relationship management solutions aimed at enhancing communication between patients and healthcare providers. Founded in 2013 and headquartered in Portland, Oregon, with additional offices in New York, Research Triangle Park, and San Francisco, Conversa offers a Virtual Care and Communication Platform designed to improve efficiency, patient engagement, and clinical outcomes. Its Digital Checkup platform automates personalized messaging based on comprehensive patient profiles developed from electronic health records, biometric devices, and self-reported data. The company serves a diverse clientele, including health systems, pharmaceutical companies, payers, and health tech firms, facilitating proactive communication and management of patients in various contexts, such as chronic care, oncology, and wellness. Conversa’s automated care platform effectively engages patients, triaging them to appropriate care settings when necessary, and has been adopted by notable organizations for its COVID-19 Virtual Care Programs, which include symptom checking, patient check-ins, and lab result delivery.
Betterview
Convertible Note in 2020
Betterview is a property intelligence platform that enables property and casualty insurers to effectively analyze, score, manage, and monitor property risk. By leveraging geospatial data and proprietary machine learning technology, Betterview transforms complex data into actionable insights, enhancing decision-making throughout the policy lifecycle. The platform aims to identify and mitigate risks while improving operational efficiency and inspection processes. Additionally, it fosters a more transparent customer experience, allowing insurers to automate critical functions such as pricing, underwriting, and renewal. Through its innovative approach, Betterview supports insurers in focusing their strategic efforts on high-risk properties, thereby enhancing overall risk management.
Attest
Venture Round in 2020
Attest Technologies Ltd., established in 2015 and headquartered in London, UK, operates a global online consumer research platform. It offers businesses real-time, on-demand consumer insights through surveys, enabling them to make data-driven decisions across various aspects such as marketing, product development, and brand tracking. Attest's platform allows direct engagement with over 110 million consumers across 45 countries, providing international research and testing solutions. The company is backed by prominent investors, including NEA, and serves clients aiming to drive predictable growth and fill knowledge gaps.
RapidSOS
Venture Round in 2020
RapidSOS, Inc. is an emergency response data platform that connects life-saving information from over 350 million devices directly to 9-1-1 and first responders during emergencies. Founded in 2012 and based in New York, the company offers a range of solutions including Clearinghouse, which enables users to send emergency requests from RapidSOS-enabled devices, and an Emergency API suite that delivers user data to emergency services. Additionally, the RapidSOS Portal provides public safety agencies with secure access to essential Next Generation 911 (NG911) data. The platform supports more than 4,800 Emergency Communications Centers and plays a vital role in protecting over 90% of the U.S. population, responding to approximately 250 million emergencies annually. By collaborating with certified partners, RapidSOS enhances response capabilities by transmitting critical data such as precise location and real-time health information, ultimately aiming to improve emergency response efficiency and save lives.
Unlearn.AI
Series A in 2020
Unlearn.AI, Inc. is a biotechnology company based in San Francisco, California, that specializes in developing innovative software tools for clinical research. Established in 2017, Unlearn.AI focuses on enhancing clinical trials through its unique digital twin technology, known as TwinRCT. This approach utilizes machine learning to create prognostic digital twins for individual patients, allowing for more accurate estimations of treatment effects while reducing the number of participants needed. The company also offers services for Clinical Trial Design, which helps determine inclusion criteria, endpoints, and study sizes, as well as Synthetic Control Arms that can minimize or eliminate the need for concurrent control groups. Additionally, Unlearn.AI provides Subgroup Analysis to identify and analyze specific patient subgroups within trial results. By integrating expertise from pharmaceuticals, medical technology, and machine learning, Unlearn.AI aims to transform clinical trials to improve outcomes for both patients and sponsors.
Adventr
Venture Round in 2020
Adventr is a technology company that offers a cloud-based platform for creating, distributing, and analyzing interactive video content. Its flagship product is a user-friendly software-as-a-service (SaaS) solution that allows users to design interactive videos using a drag-and-drop interface. This platform empowers viewers to engage with the content by making real-time choices that influence the video's narrative and actions, thereby enhancing viewer engagement. Adventr also provides tools for tracking content performance through real-time analytics, enabling users to evaluate the effectiveness of their interactive media. The company's video content can be easily embedded or shared across various online and social media platforms, making it accessible to a wide audience.
Teraki GmbH is a Berlin-based company founded in 2014 that specializes in developing software solutions designed to enhance data accessibility for various applications, including insurance, predictive maintenance, and autonomous driving. Its technology enables low-latency performance metrics, which are crucial for meeting stringent service level agreements. The company's software is specifically tailored for connected car, telematics, and autonomous vehicle applications, allowing for the handling of high volumes of data in production environments. Teraki's platform also focuses on building and refining artificial intelligence models driven by sensor data, automating the training process and improving accuracy rates. Key functionalities include crash detection, automotive insurance services, and fleet management, all aimed at optimizing operational efficiency and performance.
Usermind
Venture Round in 2019
Usermind, Inc. is a technology company that specializes in creating a unified orchestration platform aimed at enhancing business operations and customer experiences. Founded in 2013 and headquartered in Seattle, Washington, Usermind addresses the challenges posed by siloed enterprise systems and fragmented customer data. Its platform integrates various SaaS applications and on-premise systems, facilitating entity mapping and the automation of complex customer journeys. By providing a customer data platform alongside a customer journey orchestration engine and analytics capabilities, Usermind enables organizations to deliver data-driven, omnichannel engagement throughout the customer lifecycle. This comprehensive approach empowers businesses to increase revenue, enhance customer engagement, and optimize costs.
Notable Labs
Venture Round in 2019
Notable Labs, Inc. is a clinical-stage company that specializes in personalized lab testing services for cancer patients, particularly those with brain cancer. Founded in 2014 and based in Foster City, California, the company utilizes its proprietary Predictive Precision Medicines Platform to conduct drug combination experiments on patients' tumors. This platform allows Notable Labs to simulate cancer treatments and predict patient responses to specific therapies, enabling healthcare providers to prioritize combinations of FDA-approved treatments that can be prescribed without the need for clinical trials. By providing detailed reports to physicians, Notable Labs aims to enhance treatment efficacy and expedite therapeutic development for patients.
Datanomix
Series A in 2019
Datanomix, Inc. is a software company based in Nashua, New Hampshire, established in 2015. It specializes in providing a machine data analytics platform that delivers real-time insights into manufacturing productivity for industrial manufacturers. The company's software integrates machine data streams, extending its functionality beyond conventional data visualization and process productivity tools. This allows manufacturers of all sizes to access advanced decision-making resources, thereby enhancing their production efficiency, performance, and profitability. By focusing on production intelligence, Datanomix aims to support the next generation of manufacturing environments.
Pienso
Venture Round in 2019
Pienso Inc. is a machine learning platform that transforms text data into actionable insights, catering specifically to non-programming analysts, researchers, and domain experts. The platform employs advanced machine learning algorithms known as lensing to enhance both algorithmic processes and user interactions, facilitating real-time validation and adaptation. It incorporates feedback loops that enable continuous improvement through user and machine collaboration. Additionally, Pienso utilizes APIs to integrate data from existing applications, streamlining the creation and management of machine learning processes. Founded in 2016 and headquartered in Brooklyn, New York, Pienso was previously known as UBQ Labs, Inc.
Olaris
Venture Round in 2019
Olaris is a biotechnology company focused on transforming disease diagnosis and treatment through its innovative CEREBRO platform, which integrates metabolomics and machine learning. Founded in 2013 and headquartered in Framingham, Massachusetts, Olaris aims to enhance precision medicine by utilizing the body’s natural communication systems to identify biomarkers essential for treatment responsiveness. Through its myOLARIS™ precision diagnostics pipeline, the company collaborates with healthcare providers to tailor therapeutic approaches, thereby optimizing patient outcomes and minimizing adverse effects. Olaris is dedicated to advancing personalized healthcare solutions that improve the efficacy of medical interventions.